Dynamic changes in chromatin drive gene expression programs during cellular development and contribute to pathological changes underlying disease. To date, efforts to characterize chromatin dynamics ...
News Medical on MSN
Charting brain cell epigenomics to reveal origins of psychiatric disorders
In a revealing Genomic Press Interview published today in Genomic Psychiatry , Dr. Maria Margarita Behrens recounts an extraordinary scientific journey that wound through four countries and multiple ...
In recent years, the field of oncology has increasingly acknowledged cancer as a metabolic disorder with significant nutritional determinants. The advent of ...
Version 2.0 of colon cancer diagnostic will reportedly require fewer steps and be faster and easier to automate. Life Technologies is to supply Epigenomics with its Dynabeads® MyOne™ Silane and ...
Epigenomics, a transformative field in understanding the dynamic interplay between genetics and the environment, has significantly enhanced our knowledge of the brain-gut axis—a complex bidirectional ...
Company also has a lung cancer test in development. Epigenomics confirmed the European launch of Epi proColon, reportedly the first CE-marked IVD blood test for detecting colorectal cancer. The ...
KNOXVILLE, Tenn.--(BUSINESS WIRE)--New Day Diagnostics LLC is pleased to announce that it has entered into an asset purchase agreement with Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY) ...
In a revealing Genomic Press Interview published today in Genomic Psychiatry, Dr. Maria Margarita Behrens recounts an extraordinary scientific journey that wound through four countries and multiple ...
The Cancer Prevention and Research Institute (CPRIT) of Texas is supporting a Comprehensive Epigenomics Cancer Core Facility that provides consultation, instrumentation, technical support and data ...
EQS-Ad-hoc: Epigenomics AG / Key word(s): Contract/Disposal Epigenomics AG: Closing of Agreement on the Acquisition of Almost All Assets and Adjustment of Guidance for 2023 10-Oct-2023 / 20:56 ...
U.S. FDA advisers back approval for Guardant's blood-based cancer test Advisers to the U.S. Food and Drug Administration on Thursday recommended for the approval of Guardant Health's blood test to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results